Yaning Yang

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Peritoneal Dialysis

Ejection Fraction

Top Venues

Future oncology (London, England)

Cancer medicine

Asia-Pacific journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yaning Yang, Guangjian Yang, Weihua Li, Haiyan Xu, Xuezhi Hao, Shuyang Zhang, Xin Ai, Siyu Lei, Yan Wang
Immunotherapy as a later-line option for HER2 -altered advanced non-small-cell lung cancer: taxane might be a favorable partner. Future oncology (London, England) (2023)
Yaning Yang, Haiyan Xu, Li Ma, Lu Yang, Guangjian Yang, Shuyang Zhang, Xin Ai, Shucai Zhang, Yan Wang
Possibility of brigatinib-based therapy, or chemotherapy plus anti-angiogenic treatment after resistance of osimertinib harboring EGFR T790M-cis-C797S mutations in lung adenocarcinoma patients. Cancer medicine 10 (23) (2021)
Yaning Yang, Haiyan Xu, Guangjian Yang, Lu Yang, Junling Li, Yan Wang
The value of blood biomarkers of progression and prognosis in ALK-positive patients with non-small cell lung cancer treated with crizotinib. Asia-Pacific journal of clinical oncology 16 (1) (2019)